Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
[2012: news in neurology].
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
DSM-III disorders from age 11 to age 15 years.
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity.
Deep-brain stimulation for Parkinson's disease.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Diagnosis and differential diagnosis of multiple sclerosis.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
Risk of relapse phenotype recurrence in multiple sclerosis.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
Progressive multiple sclerosis: pathology and pathogenesis.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Early accurate diagnosis crucial in multiple sclerosis.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Pages
« first
‹ previous
…
271
272
273
274
275
276
277
278
279
…
next ›
last »